Camlin Fine Sciences Ltd

- There is no mention of any current or future fundraising through debt or equity in the provided transcript. - The management did not discuss plans for raising capital via equity or debt during the Q1 FY26 earnings call. - The focus was primarily on operational performance, market dynamics, tariffs, plant capacity, and margin improvements. - No indications or guidance regarding fundraising activities were shared by the management in this call.

The transcript and document on page 16 do not explicitly mention any current or future capex, capital investment, or strategic investment plans by Camlin Fine Sciences Limited during the Q1 FY26 earnings call held on August 8, 2025. The discussions focus primarily on operational performance, inventory and tariff impacts, blending business growth, vanillin sales, and cost factors related to plant shutdowns and maintenance. Summary: - No direct mention of current or planned capital expenditures or strategic investments in the provided transcript. - Main focus remains on operational issues like plant maintenance shutdown, tariff impact on vanillin business, and channel stock inventory. - Investments detailed relate mostly to increasing sales manpower (e.g., 35% increase in U.S. sales team), which is an operational expense rather than capex. - Annual plant shutdown for maintenance/upgrades (e.g., boiler upgrade) noted but no expansive capex or strategic investments discussed. If you need details beyond this transcript, the company’s quarterly filings or future investor presentations would be the best reference.

- The Blends business is expected to grow at least 15% annually in all geographies, with some regions growing faster. - Revenue projections for key regions: - Mexico (Central America): $50M+ in current year, targeting 20%+ EBITDA margin. - North America: $30-35M this year with 10-12% EBITDA margin; projected $50M+ next year with high-teen margins. - Brazil: $25-28M current year with ~10% margin; projected $35-40M next year with mid-teens margin. - CFS Vitafor: $15-16M current year with 5-10% margin; targeting $25M+ next year with margins above 10%. - Vanillin sales expected at 2,500-3,000 tons, with U.S. and Europe contributing 1,800-2,000 tons combined; rest of world 600-800 tons. - Capacity utilization anticipated to hit 70-80% by FY 2027 and full utilization by FY 2028. - Overall growth guided by stable prices and expanded sales teams, especially in the U.S. market.

- Vanillin Business: Expected volume of 2,500 to 3,000 tons annually with realizations of $13-$14 per kg on average; full capacity utilization anticipated by FY '28 with 70-80% utilization by FY '27, indicating growth potential in earnings. - Blends Business: Targeting growth across geographies at least 15%, some more, with EBITDA margins ranging from low double digits to high teens; Mexico shows ~17%+ EBITDA margins, North America aiming for mid-teens margin. - EBITDA Guidance: No specific numeric guidance, but sustained margins expected barring one-offs; sustainable gross margin estimated at 40-45% (±2-3%), slightly below recent one-off driven 50%+. - Cost Controls: Investment in sales/technical teams especially in the U.S. expected to boost business from Q3/Q4 onwards. - Tariffs & Pricing: Pricing expected to remain competitive despite tariffs, possibly resulting in slightly higher prices if tariffs persist. - China & Europe losses expected to be eliminated by end of FY ‘26, improving profitability.

- Vanillin orders for the U.S. and Europe are typically finalized around October-November for deliveries starting January. - Current inventory (channel stock) in U.S. and Europe is estimated at 1,800 to 2,000 tons; 600 to 1,200 tons for the rest of the world. - The inventory overhang in U.S. and Europe is expected to clear within 3 to 4 months from the time of discussion. - Expected vanillin sales volume is around 2,500 to 3,000 tons annually, with 1,800 to 2,000 tons from U.S. and Europe combined. - Vanillin production capacity utilization is around 50-60%, with 70-80% forecasted for FY '27 and full capacity by FY '28. - Europe contracts start business post-holiday season (September), with contract negotiations expected in September-October. - The company plans to ramp up sales significantly after channel stock clearance in Q3 of FY '26.